Supplemental Table 10.
Base Case HRQoL Regression Including Cystectomy as a Covariate
| EQ-5D Score | Coefficient | SE | z | P > z | 95% CI |
|---|---|---|---|---|---|
| EQ-5D score baseline | 0.636108 | 0.0377744 | 16.84 | .000 | 0.5620715 to 0.7101444 |
| Patient gender | 0.0477877 | 0.0163828 | 2.92 | .004 | 0.0156781 to 0.0798973 |
| Age category, y | |||||
| 50-59 | −0.0288782 | 0.0346037 | −0.83 | .404 | −0.0967001 to 0.0389438 |
| 60-69 | −0.037565 | 0.0327225 | −1.15 | .251 | −0.1016999 to 0.0265698 |
| 70-79 | −0.0464312 | 0.0342036 | −1.36 | .175 | −0.1134689 to 0.0206066 |
| >80 | −0.052182 | 0.0399786 | −1.31 | .192 | −0.1305387 to 0.0261747 |
| BMI category | |||||
| Overweight | −0.0177077 | 0.0156904 | −1.13 | .259 | −0.0484604 to 0.0130449 |
| Obese | −0.0150946 | 0.0172463 | −0.88 | .381 | −0.0488967 to 0.0187074 |
| Morbidly obese | −0.0273359 | 0.0608352 | −0.45 | .653 | −0.1465707 to 0.0918989 |
| Smoking status | |||||
| Previous | 0.0064122 | 0.0142 637 | 0.45 | .653 | −0.0215443 to 0.0343686 |
| Current | −0.0295427 | 0.0214073 | −1.38 | .168 | −0.0715001 to 0.0124148 |
| ECG result | −0.0215747 | 0.0157273 | −1.37 | .170 | −0.0523997 to 0.0092503 |
| Celecoxib treatment | −0.0081632 | 0.0129252 | −0.63 | .528 | −0.0334961 to 0.0171696 |
| Diabetes | −0.0881547 | 0.0233651 | −3.77 | .000 | −0.1339494 to −0.0423601 |
| TCC history | −0.022155 | 0.0137706 | −1.61 | .108 | −0.049145 to 0.0048349 |
| Year | |||||
| 2 | −0.0174281 | 0.0085872 | −2.03 | .042 | −0.0342587 to −0.0005975 |
| 3 | −0.0161801 | 0.0090078 | −1.80 | .072 | −0.033835 to 0.0014749 |
| Cystectomy | −0.1676828 | 0.0382576 | −4.38 | .000 | −0.2426664 to −0.0926992 |
| Constant | 0.3340947 | 0.0476971 | 7.00 | .000 | 0.24061 to 0.4275793 |
Abbreviations: BMI = body mass index; CI = confidence interval; ECG = electrocardiography; EQ-5D = EuroQoL 5-dimension; HRQoL = health-related quality of life; SE = standard error; TCC = transitional cell carcinoma.